Rivastigmine as an Antidote for Clozapine and Other Anticholinergic-Induced CNS Depression and Delirium: A Study of 100 Cases

Clinical trial NCT07545382 · COMPLETED

Trial details

NCT number: NCT07545382
Sponsor: Alexandria University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Anticholinergic Delirium Clozapine Poisoning Antipsychotic Toxicity CNS Depression Hypoactive Delirium Tricyclic Antidepressant Poisoning Procyclidine Induced Delirium

Start date: 2025-12-08
Primary completion: 2026-04-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.